Skip to main content
. 2022 Feb 25;35(3):475–489. doi: 10.1021/acs.chemrestox.1c00369

Figure 2.

Figure 2

Bioactivation pathways for acyclic (N,N-dialkyl and N-alkyl-N-aryl) and cyclic N-nitrosamines from the structural groups 1–13.